Literature DB >> 16822377

Autoimmunity and complement in the pathogenesis of chronic urticaria.

Alexander M Marsland1.   

Abstract

Chronic urticaria is a debilitating skin disease that is believed to have an underlying autoimmune etiology in 35% to 50% of cases. Patients with autoimmune urticaria have functional antibodies in their sera that release histamine from basophils and mast cells. The C5a component of complement is required for mast cell degranulation in this process and at least augments basophil histamine release. In this article, the evidence that is key to our understanding of autoimmunity and complement in the pathogenesis of a subset of patients with chronic urticaria is outlined. Some of the issues in testing for and treating autoimmune urticaria are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822377     DOI: 10.1007/s11882-006-0058-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  48 in total

1.  Association of chronic urticaria with thyroid autoimmunity and Raynaud phenomenon with anticentromere antibodies.

Authors:  Riccardo Asero; Maurizio Lorini; Alberto Tedeschi
Journal:  J Allergy Clin Immunol       Date:  2003-05       Impact factor: 10.793

2.  Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63.

Authors:  Ann De Swerdt; Caroline Van Den Keybus; Ahmad Kasran; Pascal Cadot; Karen Neyens; Lieve Coorevits; Anne-Marie Kochuyt; Hugo Degreef; Jan L Ceuppens
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

3.  Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients.

Authors:  A Leznoff; G L Sussman
Journal:  J Allergy Clin Immunol       Date:  1989-07       Impact factor: 10.793

4.  The association of chronic urticaria and angioedema with autoimmune thyroiditis.

Authors:  I Turktas; N Gokcora; S Demirsoy; N Cakir; E Onal
Journal:  Int J Dermatol       Date:  1997-03       Impact factor: 2.736

5.  Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity.

Authors:  C E Grattan; D Walpole; D M Francis; N Niimi; G Dootson; S Edler; M F Corbett; R M Barr
Journal:  Clin Exp Allergy       Date:  1997-12       Impact factor: 5.018

6.  Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies.

Authors:  R A Sabroe; P T Seed; D M Francis; R M Barr; A K Black; M W Greaves
Journal:  J Am Acad Dermatol       Date:  1999-03       Impact factor: 11.527

Review 7.  A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis.

Authors:  C M Owen; R J Chalmers; T O'Sullivan; C E Griffiths
Journal:  Br J Dermatol       Date:  2001-12       Impact factor: 9.302

8.  Assessment of autoimmunity in patients with chronic urticaria.

Authors:  L J Tong; G Balakrishnan; J P Kochan; J P Kinét; A P Kaplan
Journal:  J Allergy Clin Immunol       Date:  1997-04       Impact factor: 10.793

9.  IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera.

Authors:  M Ferrer; E Luquin; A P Kaplan
Journal:  Allergy       Date:  2003-08       Impact factor: 13.146

Review 10.  Pathophysiology of urticaria.

Authors:  Ana Hennino; Fréderic Bérard; Isabelle Guillot; Nathalie Saad; Auore Rozières; Jean-François Nicolas
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

View more
  3 in total

Review 1.  Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory disease.

Authors:  Clifton O Bingham
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

2.  Chronic urticaria.

Authors:  Sandeep Sachdeva; Vibhanshu Gupta; Syed Suhail Amin; Mohd Tahseen
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

Review 3.  Complement Activation in Inflammatory Skin Diseases.

Authors:  Jenny Giang; Marc A J Seelen; Martijn B A van Doorn; Robert Rissmann; Errol P Prens; Jeffrey Damman
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.